I've had varying opinions on Analytica over the last year or so, but I am still holding because i have one unanswered question.
Can the big players afford to ignore this one?
With the results that are being reported by clinicians, and the number of other similar (but inferior) devices emerging in the global market, their lucrative "pads" market is going to be affected at some point. Can they afford to not have this under their umbrella of products? Can they afford to let their opposition get it? Perhaps the auction idea is not so "desperate" as some may think but is actually a true representation of what is happening behind closed doors. We can only guess.
I'm no expert. This is all my opinion only.
ALT Price at posting:
0.9¢ Sentiment: Buy Disclosure: Held
